Wildy logo
(020) 7242 5778

Wildy’s Book News

Book News cover photo

Vol 23 No 4 April/May 2018

Book of the Month

Cover of Williams, Mortimer and Sunnucks: Executors, Administrators and Probate

Williams, Mortimer and Sunnucks: Executors, Administrators and Probate

Edited by: Alexander Learmonth, Charlotte Ford, Julia Clark, John Ross Martyn
Price: £295.00

Offers for Newly Called Barristers & Students

Special Discounts for Newly Called & Students

Read More ...

Secondhand & Out of Print

Browse Secondhand Online


Lowe legislation jp
Sealy millman 2018 jp
Court protection no 2
Desmith out now
Uk supremem 1 8
Williams published
This book is now Out of Print.
A new edition has been published, the details can be seen here:
Guide To EU Pharmaceutical Regulatory Law 2017 isbn 9789041169525

Guide To EU Pharmaceutical Regulatory Law 2015

Edited by: Sally Shorthose

ISBN13: 9789041166388
New Edition ISBN: 9789041169525
Previous Edition ISBN: 9789041156099
Published: October 2015
Publisher: Kluwer Law International
Country of Publication: The Netherlands
Format: Paperback
Price: Out of print

Fully revised and updated, the 6th edition contains information on the processes, legislation, cases and customs that apply to the introduction, marketing and sale of a medicinal product (or medicinal device) in Europe.

Pharmaceutical regulatory law is becoming ever more complicated, with the need to balance the constitutional requirements of the EU and its constituent Member States. This work, written by and for lawyers, will help you advise your clients on this constantly changing area.

The new edition provides you with information on the changes to clinical trials, pharmacovigilance and competition law, helping you stay abreast of new legislation.

Adopting a Europe-wide perspective on the law governing pharmaceuticals, expert authors from the law firm Bird & Bird LLP map the life cycle of a medicinal product or medical device from development to clinical trials to product launch and ongoing pharmacovigilance, providing you with comprehensive and unambiguous guidance at every stage.

Comprising three main sections, you’ll find the mainstream medicinal products from cradle to grave; specific regimes which do not fall into those categories; and three standalone chapters, dealing with an overview of what a medical device is, parallel trade, and competition law.

Following an introductory overview focusing on the regulatory framework for pharmaceuticals in Europe – from its underlying rationales to the relevant committees and agencies – each of 15 incisive chapters examines a particular process or subject. Among the many topics and issues covered are the following:

  • obtaining a marketing authorisation;
  • stages and standards for creating a product dossier;
  • clinical trials;
  • how and when an abridged procedure can be used;
  • criteria for conditional marketing authorisations;
  • generic products and ‘essential similarity’;
  • paediatric use and the requisite additional trials;
  • biologicals and ‘biosimilars’;
  • homeopathic and herbal medicines;
  • reporting procedures;
  • pharmacovigilance;
  • parallel trade;
  • relevant competition law and intellectual property rights; and
  • advertising
Extra help

  • National variation charts in many of the chapters illustrate eight major jurisdictions (Belgium, France, Germany, Italy, The Netherlands, Spain, Sweden, and the UK)
  • Includes sample forms and URLs for the most important Directives
If you work as a pharmaceutical lawyer or regulatory adviser, whether in-house or in private practice, this unique book will help you understand the process of bringing a medicinal product or medical device to market and the continuing rights and obligations.

Medical Law, EU Law
About the Editor and Authors.
List of Abbreviations.

CHAPTER 1 Overview of European Pharmaceutical Regulatory Requirements Sally Shorthose.
CHAPTER 2 Overview of Intellectual Property Rights Sally Shorthose & Tasmina Goraya.
CHAPTER 3 Clinical Trials Sally Shorthose.
CHAPTER 4 Obtaining a Marketing Authorisation Sally Shorthose & Sarah Faircliffe.
CHAPTER 5 Conditional Marketing Authorisations Sally Shorthose.
CHAPTER 6 Supplementary Protection Certificates Tasmina Goraya.
CHAPTER 7 Paediatrics Sally Shorthose & Sarah Faircliffe.
CHAPTER 8 Advertising Medicinal Products for Human Use Anne-Charlotte Le Bihan & Jean-Baptiste Thiénot (main chapter France), Sally Shorthose & Sarah Faircliffe (UK), Marc Martens & Nicolas Carbonnelle (Belgium), Ulf Grundmann (Germany), Hanneke Later-Nijland (Netherlands), Mauro Turrini (Italy), Gabriel Lidman (Sweden) and Raquel Ballesteros & Lola Canalejo Rodriguez (Spain).
CHAPTER 9 Pharmacovigilance Sally Shorthose.
CHAPTER 10 Variations to Marketing Authorisations Tasmina Goraya.
CHAPTER 11 Combination Products Sarah Faircliffe.
CHAPTER 12 Abridged Procedure Hanneke Later-Nijland.
CHAPTER 13 Orphan Drugs Sarah Faircliffe.
CHAPTER 14 Biopharmaceuticals Marc Martens & Nicolas Carbonnelle.
CHAPTER 15 Homeopathic, Herbal, and Traditional Herbal Medicinal Products Hanneke Later-Nijland.
CHAPTER 16 Advanced Therapy Medicinal Products Marc Martens & Nicolas Carbonnelle.
CHAPTER 17 Vaccines Raquel Ballesteros.
CHAPTER 18 Medical Devices Ulf Grundmann & Elisabeth Kohoutek.
CHAPTER 19 Parallel Trade Hanneke Later-Nijland.
CHAPTER 20 Competition Law in the Pharmaceutical Sector José Rivas, Carmen Feito & Eleftheria Diamanti.

Appendix Guidelines and Publications.
Table of Cases.
Other Legislation.